Revance Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Revance Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2013 to Q3 2024.
  • Revance Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.37 USD/shares, a 77.3% increase year-over-year.
  • Revance Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.97 USD/shares, a 61.2% increase year-over-year.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.83 USD/shares, a 21.8% increase from 2022.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.9 USD/shares, a 17.5% decline from 2021.
  • Revance Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -4.17 USD/shares, a 14.2% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2 $0 +$1.26 +77.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$3 $0 +$0.44 +55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$4 -$1 +$0.16 +21.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$4 -$1 +$1.25 +65.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$5 -$2 $0 -39.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$5 -$1 +$0.08 +9.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$5 -$1 +$0.20 +21.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$5 -$2 -$1 -108% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$4 -$1 $0 -6.36% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$4 -$1 +$0.19 +17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$4 -$1 +$0.14 +13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$4 -$1 +$0.33 +26.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$5 -$1 +$0.24 +17.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$5 -$1 +$0.05 +4.46% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$5 -$1 +$0.07 +6.09% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$5 -$1 Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$1 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$1 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2016 -$3 -$1 +$0.17 +21% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q2 2016 -$3 -$1 $0 -23.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-05
Q1 2016 -$3 -$1 $0 -9.23% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$3 -$1 $0 -38.3% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-04
Q3 2015 -$3 -$1 $0 -35% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$3 -$1 $0 -2.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$3 -$1 +$1.28 +66.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$4 -$1 +$53.00 +98.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-04
Q3 2014 -$57 -$1 +$55.30 +98.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-04
Q2 2014 -$112 -$1 +$74.60 +99.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-04
Q1 2014 -$187 -$2 -$28 -108% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-04
Q4 2013 -$159 -$54 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$56 Jul 1, 2013 Sep 30, 2013 10-K 2015-03-04
Q2 2013 -$75 Apr 1, 2013 Jun 30, 2013 10-K 2015-03-04
Q1 2013 $25.50 Jan 1, 2013 Mar 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.